Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
133.80    0.00 (0.00%)
Bid:
133.40
Ask:
134.80
Spread: 1.40 (1.049%)
Market Cap: £274.99m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Director/PDMR Shareholding

2 Apr 2025 14:22

RNS Number : 3945D
Forterra plc
02 April 2025
 

02 April 2025

Forterra plc

Director / PDMR Shareholding

Forterra plc (the "Company") was notified on 1 April 2025 that on the same day Katherine Innes Ker, Senior Independent Director purchased 2,600 Ordinary Shares in the Company at a price of £1.73.

Katherine Innes Ker's total beneficial interest in the Ordinary Shares of the Company now stands at 6,164 Ordinary Shares.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Frances Tock (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Katherine Innes Ker

2.

Reason for the notification

a)

Position/status

Senior Independent Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

213800O5DD6ATBVJAD23

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Purchase

1.73

2,600

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Purchase

1.73

2,600

£4,498

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUGPCUPAGWP
Date   Source Headline
16th Nov 20167:00 amRNSTrading Update
25th Oct 201610:00 amRNSGrant of Options under 2016 Sharesave Scheme
29th Sep 20165:11 pmRNSHolding(s) in Company
9th Sep 20168:58 amRNSDirector/PDMR Shareholding
7th Sep 20167:00 amRNSHalf-year Report
30th Aug 201612:02 pmRNSHolding(s) in Company
26th Aug 201611:00 amRNSAppointment of Joint Corporate Brokers
19th Aug 20169:00 amRNSPublication of comparative information for 2015
5th Jul 20167:00 amRNSPre-close trading update
15th Jun 20167:00 amRNSHolding(s) in Company
1st Jun 20163:47 pmRNSGrant under Deferred Annual Bonus Plan
1st Jun 20167:00 amRNSDirector/PDMR Shareholding
1st Jun 20167:00 amRNSTotal Voting Rights
26th May 20163:30 pmRNSHolding(s) in Company
26th May 20163:30 pmRNSHolding(s) in Company
26th May 20167:00 amRNSHolding(s) in Company
25th May 201611:20 amRNSDirector/PDMR Shareholding
25th May 201611:20 amRNSAdditional Listing
19th May 20167:00 amRNSAnalyst Meeting
22nd Apr 20164:32 pmRNSHolding(s) in Company
21st Apr 20164:37 pmRNSPublication of Prospectus
21st Apr 20167:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.